AEPODIA PARTNER IN EARLY PHASE Trademark

Trademark Overview

On Monday, September 17, 2007, a trademark application was filed for AEPODIA PARTNER IN EARLY PHASE with the United States Patent and Trademark Office. The USPTO has given the AEPODIA PARTNER IN EARLY PHASE trademark a serial number of 79049635. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, November 15, 2019. This trademark is owned by AEPODIA S.A.. The AEPODIA PARTNER IN EARLY PHASE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific investigations for medical purposes and medical research; medical and scientific research, namely, scientific, therapeutic and clinical project studies in the field of pharmaceuticals, biotechnology, metabonomics, proteonomics and genomics; medical and scientific research, namely, conducting clinical trials; development of new molecules in the field of pharmaceuticals, biotechnology, metabonomics, proteonomics and genomics
aepodia partner in early phase

General Information

Serial Number79049635
Word MarkAEPODIA PARTNER IN EARLY PHASE
Filing DateMonday, September 17, 2007
Status709 - CANCELLED - SECTION 71
Status DateFriday, November 15, 2019
Registration Number3606190
Registration DateTuesday, April 14, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 27, 2009

Trademark Statements

Indication of Colors claimedThe color(s) green and white is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the color green appears in the wording "AEPODIA PARTNER IN EARLY PHASE", the circle behind the letters "AE" and the outlines of the interlocking circles and the color white appears in the rectangular background, the letters "AE" in the circle, and inside the interlocking circle.
Goods and ServicesScientific investigations for medical purposes and medical research; medical and scientific research, namely, scientific, therapeutic and clinical project studies in the field of pharmaceuticals, biotechnology, metabonomics, proteonomics and genomics; medical and scientific research, namely, conducting clinical trials; development of new molecules in the field of pharmaceuticals, biotechnology, metabonomics, proteonomics and genomics
Pseudo MarkAE AEPODIA PARTNER IN EARLY PHASE

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 15, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAEPODIA S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBE
Party NameAEPODIA S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE
Party NameAEPODIA S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events

Event DateEvent Description
Tuesday, September 1, 2020IRREGULARITY ON INVALIDATION RECEIVED FROM IB
Monday, August 10, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, August 10, 2020INVALIDATION PROCESSED
Wednesday, July 15, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, November 15, 2019CANCELLED SECTION 71
Saturday, April 14, 2018COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, October 29, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, April 21, 2015NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Tuesday, April 21, 2015REGISTERED-SEC.71 ACCEPTED
Tuesday, April 21, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 3, 2015TEAS SECTION 71 RECEIVED
Thursday, March 27, 2014NEW REPRESENTATIVE AT IB RECEIVED
Sunday, April 14, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, April 5, 2013NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, July 29, 2009FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 29, 2009FINAL DISPOSITION PROCESSED
Tuesday, July 14, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 14, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, January 27, 2009PUBLISHED FOR OPPOSITION
Wednesday, January 7, 2009NOTICE OF PUBLICATION
Tuesday, December 23, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 23, 2008ASSIGNED TO LIE
Friday, December 12, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 2, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 2, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 21, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 21, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 21, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 21, 2008PETITION TO REVIVE-GRANTED
Friday, November 21, 2008TEAS PETITION TO REVIVE RECEIVED
Friday, October 10, 2008ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, October 10, 2008ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, April 4, 2008REFUSAL PROCESSED BY IB
Friday, March 14, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 14, 2008REFUSAL PROCESSED BY MPU
Friday, March 14, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 13, 2008NON-FINAL ACTION WRITTEN
Friday, March 7, 2008ASSIGNED TO EXAMINER
Friday, March 7, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, March 6, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

phase early partner aepodia scientific medical research field pharmaceuticals metabonomics proteonomics biotechnology clinical namely